SpotDoc Logo
Contact

This evidence-based guide explains 5-Fluorouracil (5-FU) Cream — what it treats and how well the research shows it works — written by a board-certified dermatologist.

Clinical Guides5-Fluorouracil (5-FU) CreamEvidence-based·

5-Fluorouracil (5-FU) Cream

5-fluorouracil is a prescription cream that clears sun-damaged and precancerous skin across a whole area. How it works, what the reaction looks like, and how well it works.

Built from current, peer-reviewed medical research, with every figure traced to its source, then reviewed for accuracy before publication.

Research Snapshot
31 references on this page

14 randomized trials · 5 evidence reviews · 1 clinical guideline · 11 other studies

Primary use
1Actinic keratosisHigh efficacy
Also used for
2Bowen's disease (squamous cell carcinoma in situ)Moderate efficacy3Superficial basal cell carcinomaModerate efficacy

For general education, not medical advice. This guide can’t diagnose you or replace care from your own clinician. If you’re worried about a spot or symptom, see a board-certified dermatologist.

5-Fluorouracil (5-FU) is a prescription cream that clears sun-damaged and precancerous skin. It is used most for actinic keratoses, the rough, scaly precancers caused by years of sun. Instead of treating one spot at a time, it treats a whole sun-damaged area, including early damage you cannot yet see. You may know it by the brand names Efudex, Carac, Tolak, or Fluoroplex.

Key points

  • 5-FU destroys sun-damaged and precancerous cells across a whole area, not one spot at a time.1
  • It works by causing a temporary but strong skin reaction where the damage is, then the skin heals.2
  • In a year-long head-to-head trial it kept more people clear than the other field treatments tested.3

What is 5-fluorouracil?

5-FU is a chemotherapy medicine in a cream form. On the skin, it is taken up mostly by fast-dividing, sun-damaged cells. It blocks those cells from making new DNA, so they die off. Normal skin is largely spared.2 Because it finds damage you cannot see, it is called a field treatment. It treats the whole area, not just the visible spots.1 It is a cream, so there is no cutting and no stitches.

How you use it

You put a thin layer on the treatment area at home, usually for a few weeks. The exact plan depends on the product and what is being treated:

  • Efudex (5%) is typically used twice a day for 2 to 4 weeks.
  • Carac (0.5%) is used once a day for up to 4 weeks.
  • Tolak (4%) is used once a day for 4 weeks.

A lower-strength once-daily cream can work about as well as the older twice-daily one, with less irritation, which makes the course easier to finish.4 Even short courses help, and the effect grows with a longer course.5 Your clinician will tell you exactly where, how often, and for how long to apply it.

What 5-FU treats

5-FU treats sun-damaged and early-cancerous skin across a whole area. It is used most for actinic keratoses, especially when there are many in one spot ("field cancerization"). Here is what it treats and how well the research shows it works, strongest first.

ConditionEfficacyEvidence
Primary use· 1
Established option· 1
Select cases· 1
Not appropriate· 1

Grouped by how strongly this treatment is indicated. Up bars show how well it works for each condition; green means better. Tap a study count to see the sources. Your dermatologist decides what's right for you.

Clearing a sun-damaged field is also a form of prevention, because some actinic keratoses, left alone, can turn into squamous cell carcinoma.6 5-FU is not used for invasive (deeper) skin cancers or melanoma, which need surgery or other treatments.1

What the reaction looks like

5-FU is supposed to make the treated skin look worse before it looks better. Over the first one to two weeks the area becomes red, raw, crusted, and sometimes sore, right where the sun damage is. This reaction is the treatment working. It then settles over the next couple of weeks as fresh skin comes in.2 The reaction can look alarming, but it is expected, and your clinician can tell you how to soothe the skin and when the course is done.

How well it works

The table above summarizes the evidence by condition. The detail below adds the key numbers.

For actinic keratoses, 5-FU is a first-line field treatment. One large trial compared four field treatments. A year later, 74.7% of people stayed clear with 5-FU. The others were lower: 53.9% for imiquimod, 37.7% for photodynamic therapy, and 28.9% for ingenol mebutate gel.37 Major guidelines strongly recommend it.8 One honest caveat: spots come back. When the whole treated area was checked at a year, only about a third of people stayed fully clear. So a course is sometimes repeated over time.9

Adding a second cream, calcipotriol, for a short 4-day course boosted short-term clearance well beyond 5-FU alone in one trial.10 A review found this combination also lowered later squamous cell cancers on the face and scalp; in the same research it did not change the rate of basal cell cancers.1112 5-FU is also commonly paired with freezing, which can clear more spots than freezing alone.1314

A separate idea is prevention: one short course of 5-FU to the face and ears cut the number of squamous cell cancers needing surgery by about 75% in the first year in a large veterans trial, though it did not lower basal cell cancers and the benefit faded after that first year.15 It also lowered first-year treatment costs.16

For Bowen's disease (squamous cell carcinoma in situ), a 250-person trial found 5-FU non-inferior to surgically removing the spot, with a better cosmetic result. About 86% of treated spots stayed clear at both 1 and 4 years, and no squamous cell cancer arose in any treated area over the longer follow-up. Surgery still clears the most spots, so it stays the choice when the priority is the highest cure rate.1718 For superficial basal cell carcinoma, 5-FU is an option, but imiquimod tends to clear more (see the table above).19 For how 5-FU compares with freezing and other creams for actinic keratoses, see the actinic keratosis guide.

Other options patients ask about

People often look for something gentler than the 5-FU reaction, or a "natural" way to avoid it. Here is what the evidence shows.

  • Imiquimod, photodynamic therapy, and diclofenac gel are real, proven alternatives. Imiquimod can leave a better cosmetic result and more lasting clearance, but takes a longer course; diclofenac is gentler but clears less.98 These belong on their own pages and are worth discussing, but they are reasons to pick a different treatment, not to skip treatment.
  • Tirbanibulin is a newer, shorter cream (5 days). In a 2026 trial it cleared about as well as 5-FU short-term and was better tolerated, though its longer-term staying power is less established.20
  • Ingenol mebutate (Picato) is no longer available. It was withdrawn from the market after data linked it to more skin cancers in treated areas, and it was the least effective option in the head-to-head trial.3
  • Apple cider vinegar and other "natural" topicals have no evidence for clearing precancers, and home acids can burn the skin and hide a growing cancer.
  • Black salve and similar corrosive pastes are harmful. They are sold online as a skin cancer cure. But the claims are not evidence-based, and serious injuries have been reported. They can also leave cancer behind under a scab where no one can see it.2122

Why getting the spot checked first matters

5-FU treats the surface. That is the whole reason a diagnosis comes first. A spot that looks like a simple precancer, or a "superficial" basal cell carcinoma, can be something deeper. Studies show deeper cancers are sometimes missed at the start and only found after a cream fails.23 Treating yourself with a cream, an acid, or a corrosive paste can destroy the tissue a doctor needs to make the diagnosis. It can also let a real cancer grow. A skin exam and, when needed, a biopsy come first.

Who should not use it

5-FU is a prescription medicine with real cautions:

  • Pregnancy. 5-FU should not be used during pregnancy, and it is not advised while breastfeeding. Tell your clinician if you are or could be pregnant.
  • A rare enzyme deficiency (DPD). A small number of people lack enough of the enzyme that breaks 5-FU down. In them, even a cream can rarely cause serious whole-body effects. Tell your clinician about any past severe reaction to fluorouracil or related chemotherapy.2425
  • The Tolak (4%) cream contains peanut oil; ask your clinician if you have a peanut allergy, though the studied product was reported safe in peanut-allergic patients.4

When to see a doctor

Call your clinician if the reaction becomes very painful, oozing, or looks infected, if it spreads well beyond the treated area, or if a spot does not heal after the course is finished. And see a clinician before starting any cream on a spot that is new, changing, bleeding, or different from your others, so it can be properly checked first.

Worried about a spot?

SpotDoc offers full-body skin cancer screening in Brownwood Square, The Villages. No referral needed for most plans.

Frequently asked questions

Is 5-FU cream chemotherapy? Yes, it is a chemotherapy medicine, but used as a cream it acts mostly on the skin where you apply it, not throughout the body.2 That is different from chemotherapy given through a vein.

Why does my skin look so bad while using it? That reaction is the treatment working. 5-FU inflames and clears the sun-damaged cells, so the area gets red and crusted before it heals over a few weeks.2

How well does it work compared with other options? For actinic keratoses, it kept more people clear at one year than imiquimod, photodynamic therapy, or ingenol mebutate in a head-to-head trial.3 Newer tirbanibulin cleared about as well short-term and was better tolerated.20

Can I stop early if the reaction is bad? Talk to your clinician first. Longer courses tend to work better, but a gentler once-daily cream can give a similar result with less irritation, so there may be an easier option than quitting.54

Will the spots stay gone? Often not for good. Sun-damaged skin keeps making new spots, so many people need a repeat course over the years.9

Can I use a natural remedy instead? There is no proven natural substitute, and corrosive "black salve" pastes are dangerous and can hide a cancer. Get the spot checked and use a treatment that is known to work.2122

Questions to ask your clinician

  • Has this spot been examined, and does it need a biopsy before I treat it?
  • Which product and schedule fit my skin and my daily routine?
  • What should the reaction look like, and how do I care for the skin?
  • When should I call you, and when is the course finished?
  • Could I or should I be pregnant, and does that change the plan?

5-FU is one of several field treatments. Others include photodynamic therapy and imiquimod, compared side by side in the actinic keratosis guide. The best choice depends on how much sun damage you have, your schedule, and how your skin tolerates treatment. A thorough skin cancer screening is the place to start.

Reviewed by Tyler Long, DO. Last reviewed 2026-06-22.

Update log

How this guide has changed since it was first published.

  1. August 25, 2026Guide published.

References

Every statement on this page is backed by the peer-reviewed sources below — each links to the original study. Numbers match the citations in the text and the grids above.

  1. Cornejo CM, Jambusaria-Pahlajani A, Willenbrink TJ, et al. Field cancerization: Treatment. J Am Acad Dermatol. 2020;83(3):719–730.View source
  2. Micali G, Lacarrubba F, Nasca MR, Schwartz RA. Topical pharmacotherapy for skin cancer: part I. Pharmacology. J Am Acad Dermatol. 2014;70(6):965.e1–12.View source
  3. Jansen MHE, Kessels JPHM, Nelemans PJ, et al. Randomized Trial of Four Treatment Approaches for Actinic Keratosis. N Engl J Med. 2019;380(10):935–946.View source
  4. Dohil MA. Efficacy, Safety, and Tolerability of 4% 5-Fluorouracil Cream in a Novel Patented Aqueous Cream Containing Peanut Oil Once Daily Compared With 5% 5-Fluorouracil Cream Twice Daily in the Treatment of Actinic Keratosis. J Drugs Dermatol. 2016;15(10):1218–1224.View source
  5. Weiss J, Menter A, Hevia O, et al. Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks. Cutis. 2002;70(2 Suppl):22–29.View source
  6. Calzavara-Pinton P, Calzavara-Pinton I, Rovati C, Rossi M. Topical Pharmacotherapy for Actinic Keratoses in Older Adults. Drugs Aging. 2022;39(2):143–152.View source
  7. Wehner MR. Comparing the efficacy of field treatments for actinic keratosis: a critical appraisal of a randomized trial in the New England Journal of Medicine. Br J Dermatol. 2020;182(6):1343–1344.View source
  8. Eisen DB, Asgari MM, Bennett DD, et al. Guidelines of care for the management of actinic keratosis. J Am Acad Dermatol. 2021;85(4):e209–e233.View source
  9. Krawtchenko N, Roewert-Huber J, Ulrich M, Mann I, Sterry W, Stockfleth E. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol. 2007;157 Suppl 2:34–40.View source
  10. Cunningham TJ, Tabacchi M, Eliane JP, et al. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy. J Clin Invest. 2017;127(1):106–116.View source
  11. Lapidus AH, Lee S, Liu ZF, Smithson S, Chew CY, Gin D. Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis, Bowen's Disease, and Squamous Cell Carcinoma: A Systematic Review. J Cutan Med Surg. 2024;28(4):375–380.View source
  12. Rosenberg AR, Tabacchi M, Ngo KH, et al. Skin cancer precursor immunotherapy for squamous cell carcinoma prevention. JCI Insight. 2019;4(6):e125476.View source
  13. Hoover WD, Jorizzo JL, Clark AR, Feldman SR, Holbrook J, Huang KE. Efficacy of cryosurgery and 5-fluorouracil cream 0.5% combination therapy for the treatment of actinic keratosis. Cutis. 2014;94(5):255–259.View source
  14. Jorizzo J, Weiss J, Vamvakias G. One-week treatment with 0.5% fluorouracil cream prior to cryosurgery in patients with actinic keratoses: a double-blind, vehicle-controlled, long-term study. J Drugs Dermatol. 2006;5(2):133–139.View source
  15. Weinstock MA, Thwin SS, Siegel JA, et al. Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial. JAMA Dermatol. 2018;154(2):167–174.View source
  16. Yoon J, Phibbs CS, Chow A, Weinstock MA. Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis. J Am Acad Dermatol. 2018;79(3):501–507.e2.View source
  17. Ahmady S, Nelemans PJ, Kelleners-Smeets NWJ, et al. Surgical excision versus topical 5% 5-fluorouracil and photodynamic therapy in treatment of Bowen's disease: A multicenter randomized controlled trial. J Am Acad Dermatol. 2024;90(1):58-65.View source
  18. Moermans MMG, Ahmady S, Nelemans PJ, et al. Surgical excision versus topical 5% 5-fluorouracil and photodynamic therapy in the treatment of Bowen's disease: Long-term results of a multicenter randomized controlled trial. J Am Acad Dermatol. 2025;94(5):1447-1453.View source
  19. Arits AHMM, Mosterd K, Essers BAB, et al. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol. 2013;14(7):647–654.View source
  20. Venturi F, Magnaterra E, Gualandi A, et al. Randomized comparative study of 5-Fluorouracil 4%, tirbanibulin, and photodynamic therapy for relapsing actinic keratoses. Photodiagnosis Photodyn Ther. 2026;58:105359.View source
  21. Croaker A, Lim A, Rosendahl C. Black salve in a nutshell. Aust J Gen Pract. 2018;47(12):864–867.View source
  22. Leecy TN, Beer TW, Harvey NT, et al. Histopathological features associated with application of black salve to cutaneous lesions: a series of 16 cases and review of the literature. Pathology. 2013;45(7):670–674.View source
  23. van Delft LCJ, Nelemans PJ, Jansen MHE, et al. Histologic subtype of treatment failures after noninvasive therapy for superficial basal cell carcinoma: An observational study. J Am Acad Dermatol. 2019;80(4):1022–1028.View source
  24. Garcia RM, Mobilia M, Newcomer JB, Wilson CL. Focal Neurotoxicity Associated With Topical 5-Fluorouracil. Cureus. 2024;16(2):e54365.View source
  25. Cohen PR. Topical application of 5-fluorouracil 5 percent cream associated with severe neutropenia: discussion of a case and review of systemic reactions after topical treatment with 5-fluorouracil. Dermatol Online J. 2018;24(4):13030/qt974797j7.View source
  26. Gupta AK, Paquet M, Villanueva E, Brintnell W. Interventions for actinic keratoses. Cochrane Database Syst Rev. 2012;12:CD004415.View source
  27. Ezzedine K, Painchault C, Brignone M. Systematic Literature Review and Network Meta-analysis of the Efficacy and Acceptability of Interventions in Actinic Keratoses. Acta Derm Venereol. 2021;101(1):adv00358.View source
  28. Bath-Hextall FJ, Matin RN, Wilkinson D, Leonardi-Bee J. Interventions for cutaneous Bowen's disease. Cochrane Database Syst Rev. 2013;(6):CD007281.View source
  29. Foerster Y, Mayer K, Dechant M, et al. Interventions for Bowen's disease: A systematic review and network meta-analysis of randomized controlled trials. J Dtsch Dermatol Ges. 2025;23(11):1373-1385.View source
  30. Shimizu I, Cruz A, Chang KH, Dufresne RG. Treatment of squamous cell carcinoma in situ: a review. Dermatol Surg. 2011;37(10):1394–1411.View source
  31. Roozeboom MH, Arits AHMM, Mosterd K, et al. Three-Year Follow-Up Results of Photodynamic Therapy vs. Imiquimod vs. Fluorouracil for Treatment of Superficial Basal Cell Carcinoma: A Single-Blind, Noninferiority, Randomized Controlled Trial. J Invest Dermatol. 2016;136(8):1568–1574.View source

Worried about a spot? We can take a look.

SpotDoc offers full-body skin cancer screening in The Villages. No referral needed.